University of Minnesota

516 Delaware St. SE
Minneapolis, MN 55455
United States
Call 612-624-2922 Email this location

University of Minnesota is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Antoinette Moran, MD, the TrialNet team at University of Minnesota is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Our Team

Principal Investigators 
Antoinette
Moran
MD
Brandon
Nathan
MD
Jennifer
McVean
MD
Muna
Sunni
MD
Research Coordinators 
Beth
Pappenfus
Anne
Street
RN
Brittney
Nelson
Janice
Leschyshyn
RN
Nancy
Vang

Regional Affiliates

Ames

Mary Greeley Medical Center Diabetes Center
1111 Duff Ave, Ames, IA 50010

Des Moines

Central Iowa Hospital Corporation
1215 Pleasant St., Ste 300, Des Moines, IA 50309

Fargo

Sanford Research - Fargo
737 Broadway N, Fargo, ND 58122

Florissant

Esse Health, Pediatric Endocrinology
1125 Graham Rd, Building C, Ste 1350, Florissant, MO 63031

Grand Folks

Altru Health System - Research Dept.
860 South Columbia Road, Grand Folks, ND 58201

Iowa City

University of Iowa, Childrens Hospital of Iowa
25 S Grand Avenue 2160 ML, Iowa City, IA 52242

Rapid City

Regional Health Clinical Research
735 Meade Street, Rapid City, SD 57701

Sioux Falls

Sanford Childrens Specialty Clinic
1018 West 18th Street, Sioux Falls, SD 57104

St. Paul

Childrens Hospital & Clinics of Minnesota
345 N. Smith Ave MS70-404, St. Paul, MN 55102

Research Studies

Risk Screening

Pathway to Prevention

If you have a relative with T1D, you’re in a unique position to help us learn more about the disease and how to stop it. The first step is to sign up for Pathway to Prevention screening to determine your risk of developing T1D.

More

Prevention Study

Abatacept

TrialNet is testing the drug abatacept to see if it can delay or prevent progression of early stage T1D (stage 1 to stage 2) and ultimately prevent clinical diagnosis (stage 3). In earlier studies for people newly diagnosed (stage 3), abatacept helped slow down disease progression.

More

Teplizumab

We are testing the drug teplizumab to see if it can delay or prevent progression of early stage T1D (stage 2) and prevent clinical diagnosis (stage 3). In earlier studies in people newly diagnosed (stage 3), teplizumab helped to prolong insulin production.

More

Longterm

Long-Term Investigative Follow-Up in TrialNet (LIFT)

Once your study ends, we're still here for you. Participant monitoring and continued involvement helps us learn more about T1D.

More